SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
+13.67%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$871M
AUM Growth
+$290M
(+50%)
Cap. Flow
+$211M
Cap. Flow
% of AUM
24.19%
Top 10 Holdings %
Top 10 Hldgs %
66.75%
Holding
73
New
20
Increased
22
Reduced
4
Closed
14
Top Buys
| 1 |
Iterum Therapeutics
ITRM
|
$18.8M |
| 2 |
AGN
Allergan plc
AGN
|
$17M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.3M |
| 4 |
Kiniksa Pharmaceuticals
KNSA
|
$16M |
| 5 |
CELG
Celgene Corp
CELG
|
$14.6M |
Top Sells
| 1 |
NCNA
NuCana
NCNA
|
$76.2M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$17.1M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$6.51M |
| 4 |
ATYR
aTyr Pharma
ATYR
|
$4.95M |
| 5 |
Bristol-Myers Squibb
BMY
|
$951K |
Sector Composition
| 1 | Healthcare | 82.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDMN
26
DELISTED
Kadmon Holdings, Inc.
KDMN
| $6.06M | 0.69% |
1,769,583
+1,582,809
| +847% | +$5.42M |
|
27
Esperion Therapeutics
ESPR
$538M
| $5.92M | 0.67% |
+151,161
| New | +$5.92M |
|
|
BPMC
28
DELISTED
Blueprint Medicines
BPMC
| $5.85M | 0.66% |
+92,200
| New | +$5.85M |
|
29
Synlogic
SYBX
$17.1M
| $5.65M | 0.64% |
38,331
| – | – |
|
30
Ocugen
OCGN
$319M
| $5.19M | 0.59% |
34,617
| – | – |
|
31
Clearside Biomedical
CLSD
$27.5M
| $4.63M | 0.52% |
432,904
+397,525
| +1,124% | +$4.25M |
|
32
Catalyst Pharmaceutical
CPRX
$2.43B
| $4.52M | 0.51% |
1,449,957
+1,301,902
| +879% | +$4.06M |
|
33
Rhythm Pharmaceuticals
RYTM
$6.86B
| $4.39M | 0.5% |
+140,300
| New | +$4.39M |
|
34
PTC Therapeutics
PTCT
$4.56B
| $4.29M | 0.49% |
127,079
+101,350
| +394% | +$3.42M |
|
35
KALA BIO
KALA
$103M
| $4.17M | 0.47% |
6,074
+5,665
| +1,385% | +$3.89M |
|
|
OTIC
36
DELISTED
Otonomy, Inc.
OTIC
| $3.77M | 0.43% |
979,978
+881,354
| +894% | +$3.39M |
|
|
HSTO
37
DELISTED
Histogen Inc. Common Stock
HSTO
| $3.68M | 0.42% |
+4,294
| New | +$3.68M |
|
38
Puma Biotechnology
PBYI
$256M
| $3.66M | 0.42% |
+61,936
| New | +$3.66M |
|
|
SPPI
39
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $3.56M | 0.4% |
+169,965
| New | +$3.56M |
|
|
FOMX
40
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.42M | 0.39% |
682,399
+610,382
| +848% | +$3.06M |
|
|
DERM
41
DELISTED
Dermira, Inc.
DERM
| $3.35M | 0.38% |
364,340
+316,020
| +654% | +$2.91M |
|
|
RETA
42
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.14M | 0.36% |
89,909
+60,526
| +206% | +$2.12M |
|
43
Kura Oncology
KURA
$713M
| $3.06M | 0.35% |
+167,900
| New | +$3.06M |
|
44
PDS Biotechnology
PDSB
$55.5M
| $2.94M | 0.33% |
142,636
| – | – |
|
45
Savara
SVRA
$638M
| $2.91M | 0.33% |
+256,692
| New | +$2.91M |
|
|
AMAG
46
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $2.78M | 0.31% |
+142,511
| New | +$2.78M |
|
|
CHMA
47
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $2.45M | 0.28% |
1,767,102
+136,881
| +8% | +$189K |
|
|
KDNY
48
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.69M | 0.19% |
48,264
+44,925
| +1,345% | +$1.57M |
|
|
CALA
49
DELISTED
Calithera Biosciences, Inc
CALA
| $1.49M | 0.17% |
14,861
+13,865
| +1,392% | +$1.39M |
|
|
OMED
50
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $915K | 0.1% |
396,244
+329,211
| +491% | +$760K |
|